Core Points - The company held the eighth meeting of the fifth supervisory board on August 22, 2025, with all three supervisors present, confirming the meeting's legality and effectiveness [1] - The supervisory board unanimously approved the 2025 semi-annual report, stating it accurately reflects the company's financial status and operational results without any false records or misleading statements [1] - The board also approved a special report on the use of raised funds for the first half of 2025, which will be disclosed on the designated information disclosure website [1]

Group 1 - The meeting of the eighth supervisory board of Tongyuan Petroleum Technology Group Co., Ltd. was held on August 22, 2025, via communication voting, with all three supervisors present [1] - The supervisory board approved the company's 2025 semi-annual report, confirming that the report's preparation and review processes complied with relevant laws and regulations, and accurately reflected the company's actual situation [1][2] - The report detailed the management and usage of the funds raised in 2025, indicating that the company adhered to legal requirements and did not misuse the funds or alter their intended use [2] Group 2 - The company decided to dissolve the supervisory board, transferring its powers to the audit committee of the board of directors, with the relevant rules being abolished [2] - This decision requires approval from the company's shareholders' meeting and must be passed as a special resolution [2]

Meeting Details - The third meeting of the supervisory board of Shenzhen Longte Intelligent Control Co., Ltd. was held on August 20, 2025, combining in-person and remote attendance [1] - The meeting was chaired by the chairman of the supervisory board, Mr. Wei Yongxiao, with all three supervisors present [1] Meeting Resolutions - The supervisory board concluded that the procedures for the preparation and review of the 2025 semi-annual report and its summary complied with relevant laws and regulations, and the report accurately reflected the company's actual situation without any false records or misleading statements [1][2] - The supervisory board also reviewed the management, use, and operation procedures of the raised funds, confirming compliance with the regulations and that the actual use of funds aligned with the promised direction [2]

证券代码：301120 证券简称：新特电气 公告编号：2025-049 新华都特种电气股份有限公司（以下简称"公司"）第五届监事会第十次会议通 知于 2025 年 8 月 11 日以电子邮件、通讯的方式发出，会议于 2025 年 8 月 21 日上午 在公司二楼会议室以现场结合通讯表决的方式召开，会议应参加表决监事 3 名，实 际参加表决监事 3 名，本次会议由监事会主席苏静女士主持，公司董事会秘书段婷 婷女士列席了会议。会议的召开及表决程序符合《公司法》《公司章程》《监事会议 事规则》的有关规定。 二、监事会会议审议情况 经全体监事审议并表决，一致通过以下议案： 经审议，监事会认为：公司《2025 年半年度报告》及其摘要的编制和审议程序 符合法律、法规等的各项规定；报告内容真实、准确、完整地反映了公司 2025 年上 半年经营的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的相关公告。 新华都特种电气股份有限公司 第五届监事会第十次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈 ...

证券代码：300270 证券简称：中威电子 公告编号：2025-031 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载，误导性 陈述或重大遗漏。 一、监事会会议召开情况 杭州中威电子股份有限公司（以下简称"公司"）第五届监事会第二十一次会议通知于2025年8月1日以 电子邮件形式送达公司全体监事，会议于2025年8月13日10:30在公司18楼会议室以现场和通讯表决相结 合的 方式召开。本次监事会应出席会议的监事3名，实际出席会议的监事3名（其中：以通讯表决方式出席会 议的 二、监事会会议审议情况 表决结果：3 票同意、0 票反对、0 票弃权，表决通过。 监事会认为：公司编制和审议《2025 年半年度报告全文》及其摘要的程序符合法律、法规、中国证 监 监事1名，为：杨洒）。会议由监事会主席杨洒女士主持，董事会秘书列席了会议。本次会议的召开符 合《中 华人民共和国公司法》 （以下简称"《公司法》"）、 《中华人民共和国证券法》 （以下简称"《证券法》"）等有关 法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 会和深圳证券交易所的相关规定，报告内容真实、准确、完整地反映了公司 ...

Meeting Overview - The fourth meeting of the Supervisory Board of Tibet Gaozheng Mining Explosives Co., Ltd. was held on August 11, 2025, with all five supervisors present, confirming the legality and validity of the meeting procedures [1]. Resolutions Passed - The Supervisory Board unanimously approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's actual situation without any false statements or omissions [1][2]. - The board approved an estimated new daily related transaction of 18 million yuan with Tibet Zhongjin Xinlian Blasting Engineering Co., Ltd. for the year 2025, based on market pricing principles [2][3]. - The board also approved an estimated new related transaction of 25 million yuan with a subsidiary of the controlling shareholder, Tibet Jian Group, for the year 2025, with the voting process ensuring that related supervisors recused themselves from the decision [3]. Disclosure - The announcements regarding the new related transactions will be published in major financial newspapers and on the official website [2][3].

证券代码：300590 证券简称：移为通信 公告编号：2025-045 上海移为通信技术股份有限公司 第四届监事会第十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 监事会会议召开情况 上海移为通信技术股份有限公司（以下简称"公司"）第四届监事会第十一 次会议于 2025 年 7 月 30 日（星期三）在上海市闵行区新龙路 500 弄 30 号 6 楼会 议室以现场结合通讯的方式召开。会议通知已于会议召开 10 日前通过邮件的方式 送达各位监事。本次会议由监事会主席提议召开，应出席监事 3 人，实际出席监 事 3 人。 会议由监事会主席王晓桦女士主持，公司董事会秘书列席了本次会议。会议 召开符合《中华人民共和国公司法》《公司章程》和《监事会议事规则》的有关 规定。出席会议的监事对各项议案进行了认真审议并做出了如下决议： 二、 监事会会议审议情况 经审议，监事会认为：公司董事会编制和审核《2025 年半年度报告》及《2025 年半年度报告摘要》的程序符合法律、行政法规和中国证监会的规定，报告内容 真实、准确、完整地反映了公司的实际情况，不 ...

Meeting Details - The fourth meeting of the Supervisory Board of Zhonghong Pulin Medical Supplies Co., Ltd. was held on May 30, 2025, via communication methods, with a notice sent to all supervisors on May 25, 2025 [1] - All three supervisors participated in the voting, and the meeting was chaired by Mr. Zhou Zhaohua [1] Investment Proposal - The Supervisory Board approved the company's plan to invest in the construction of a glove production line using self-owned or raised funds, which complies with relevant regulations and is in the interest of the company and all shareholders [1] - The proposal received unanimous support with 3 votes in favor, 0 against, and 0 abstentions, and it will be submitted to the shareholders' meeting for further review [2] Changes in Supervisory Board - Mr. Zhou Zhaohua applied for resignation from his position as a non-employee representative supervisor and chairman of the Supervisory Board due to personal work adjustments, which will temporarily reduce the number of supervisors below the legal minimum [2] - The Supervisory Board nominated Ms. Yu Lijie as a candidate for the non-employee representative supervisor, pending approval at the next extraordinary shareholders' meeting [2]

Core Viewpoint - The announcement details the resolutions passed during the 12th meeting of the 8th Supervisory Board of Jiangsu Kangyuan Pharmaceutical Co., Ltd., including the approval of the 2024 annual report, supervisory work report, financial settlement report, and other significant matters related to the company's operations and governance [1][2][3]. Group 1: Annual Report and Financials - The Supervisory Board approved the 2024 Annual Report and its summary, confirming that the report accurately reflects the company's operational and financial status for the year [1][2]. - The 2024 Financial Settlement Report was also approved, which objectively and truthfully reflects the company's financial condition and operational results for the year [6]. Group 2: Supervisory Board Activities - The Supervisory Board held six meetings during the reporting period, with all five supervisors present at each meeting, ensuring compliance with legal and regulatory requirements [2][3]. - The Board's activities included oversight of financial management, risk control, and compliance with corporate governance, contributing positively to the company's healthy development and protection of shareholder rights [2][3]. Group 3: Internal Control and Compliance - The Supervisory Board reviewed the internal control evaluation report for 2023, finding that the internal control system is effective and meets relevant requirements, thereby providing good risk prevention and control [5][7]. - The Board confirmed that the company operated in accordance with laws and regulations, with no violations or actions that could harm shareholder interests [3][4]. Group 4: Related Party Transactions - The Board approved the expected related party transactions for 2025, determining that they are necessary for the company's operational development and comply with legal pricing principles [6][8]. - The Board found that all related party transactions were conducted at fair market prices and followed proper decision-making procedures, ensuring no detriment to the company or its shareholders [4][6]. Group 5: Stock Incentive Plan - The Supervisory Board approved the proposal to repurchase and cancel all remaining restricted stocks from the 2022 stock incentive plan, confirming that the process followed appropriate procedures and would not materially affect the company's financial status [8].

Core Points - The supervisory board of Midea Group held its fifth meeting on March 28, 2025, and all resolutions were passed unanimously with three votes in favor [1][2][3] Group 1: Supervisory Board Resolutions - The supervisory board approved the 2024 Annual Work Report, which will be submitted to the shareholders' meeting for review [1] - The 2024 Annual Financial Settlement Report was also approved and will be submitted to the shareholders' meeting [2] - The 2024 Annual Report and its summary were approved, with the supervisory board confirming that the report accurately reflects the company's situation [1][2] - The 2024 Profit Distribution Plan was approved, deemed beneficial for the company's stable development and in line with the company's articles of association [2] - The A-share holding plan for 2024 was approved, with the supervisory board affirming it aligns with relevant laws and does not harm shareholder interests [2][3] - The management measures for the 2025 A-share holding plan were approved, confirming compliance with regulations [3] - The proposal to provide guarantees for subsidiaries in 2025 was approved, seen as beneficial for the company's main business and financial structure [3][4] - The internal control evaluation report for 2024 was approved, indicating that the company has established effective internal control systems [4]